MFDS — authorised 14 December 2020
- Marketing authorisation holder: ALMIRALL
- Status: likely_approved
🇰🇷 Klisyri in South Korea
MFDS authorised Klisyri on 14 December 2020
Marketing authorisation
Klisyri in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in South Korea
Frequently asked questions
Is Klisyri approved in South Korea?
Yes. MFDS authorised it on 14 December 2020.
Who is the marketing authorisation holder for Klisyri in South Korea?
ALMIRALL holds the South Korean marketing authorisation.